High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATS

• Main Authors: Sarah J. Tozer (Author), Helen V. Smith (Author), David M. Whiley (Author), Ray Borrow (Author), Giuseppe Boccadifuoco (Author), Duccio Medini (Author), Davide Serruto (Author), Marzia Monica Giuliani (Author), Maria Stella (Author), Rosita De Paola (Author), Alessandro Muzzi (Author), Mariagrazia Pizza (Author), Theo P. Sloots (Author), Michael D. Nissen (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Neisseria adhesin A (NadA), and outer membrane vesic...